Search tips
Search criteria 


Logo of jmedgeneJournal of Medical GeneticsVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
J Med Genet. 1998 May; 35(5): 353–365.
PMCID: PMC1051308

Hereditary fructose intolerance.


Hereditary fructose intolerance (HFI, OMIM 22960), caused by catalytic deficiency of aldolase B (fructose-1,6-bisphosphate aldolase, EC, is a recessively inherited condition in which affected homozygotes develop hypoglycaemic and severe abdominal symptoms after taking foods containing fructose and cognate sugars. Continued ingestion of noxious sugars leads to hepatic and renal injury and growth retardation; parenteral administration of fructose or sorbitol may be fatal. Direct detection of a few mutations in the human aldolase B gene on chromosome 9q facilitates the genetic diagnosis of HFI in many symptomatic patients. The severity of the disease phenotype appears to be independent of the nature of the aldolase B gene mutations so far identified. It appears that hitherto there has been little, if any, selection against mutant aldolase B alleles in the population: in the UK, approximately 1.3% of neonates harbour one copy of the prevalent A149P disease allele. The ascendance of sugar as a major dietary nutrient, especially in western societies, may account for the increasing recognition of HFI as a nutritional disease and has shown the prevalence of mutant aldolase B genes in the general population. The severity of clinical expression correlates well with the immediate nutritional environment, age, culture, and eating habits of affected subjects. Here we review the biochemical, genetic, and molecular basis of human aldolase B deficiency in HFI, a disorder which responds to dietary therapy and in which the principal manifestations of disease are thus preventable.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (3.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • VANDERHEIDEN BS, MEINHART JO, DODSON RG, KREBS EG. The preparation and properties of crystalline yeast aldolase. J Biol Chem. 1962 Jul;237:2095–2098. [PubMed]
  • HORECKER BL, PONTREMOLI S, RICCI C, CHENG T. On the nature of the transaldolase-dihydroxyacetone complex. Proc Natl Acad Sci U S A. 1961 Dec 15;47:1949–1955. [PubMed]
  • Penhoet E, Rajkumar T, Rutter WJ. Multiple forms of fructose diphosphate aldolase in mammalian tissues. Proc Natl Acad Sci U S A. 1966 Oct;56(4):1275–1282. [PubMed]
  • Penhoet EE, Kochman M, Rutter WJ. Ioslation of fructose diphosphate aldolases A, B, and C. Biochemistry. 1969 Nov;8(11):4391–4395. [PubMed]
  • Munnich A, Besmond C, Darquy S, Reach G, Vaulont S, Dreyfus JC, Kahn A. Dietary and hormonal regulation of aldolase B gene expression. J Clin Invest. 1985 Mar;75(3):1045–1052. [PMC free article] [PubMed]
  • Adelman RC, Spolter PD, Weinhouse S. Dietary and hormonal regulation of enzymes of fructose metabolism in rat liver. J Biol Chem. 1966 Nov 25;241(22):5467–5472. [PubMed]
  • Arnold H, Pette D. Binding of aldolase and triosephosphate dehydrogenase to F-actin and modification of catalytic properties of aldolase. Eur J Biochem. 1970 Aug;15(2):360–366. [PubMed]
  • Weiss TL, Zieske JD, Bernstein IA. Reversible microsomal binding of hepatic aldolase. Biochim Biophys Acta. 1981 Oct 13;661(2):221–229. [PubMed]
  • Hommes FA, Draisma MI. The development of L- and M-type aldolases in rat liver. Biochim Biophys Acta. 1970 Oct 27;222(1):251–252. [PubMed]
  • Numazaki M, Tsutsumi K, Tsutsumi R, Ishikawa K. Expression of aldolase isozyme mRNAs in fetal rat liver. Eur J Biochem. 1984 Jul 2;142(1):165–170. [PubMed]
  • Matsushima T, Kawabe S, Shibuya M, Sugimura T. Aldolase isozymes in rat tumor cells. Biochem Biophys Res Commun. 1968 Mar 12;30(5):565–570. [PubMed]
  • Tsutsumi K, Tsutsumi R, Ishikawa K. Tissue-specific changes in chromatin structure of the rat aldolase B locus. J Biochem. 1987 Nov;102(5):1013–1021. [PubMed]
  • Zhao Y, Tsutsumi R, Yamaki M, Nagatsuka Y, Ejiri S, Tsutsumi K. Initiation zone of DNA replication at the aldolase B locus encompasses transcription promoter region. Nucleic Acids Res. 1994 Dec 11;22(24):5385–5390. [PMC free article] [PubMed]
  • Daimon M, Tsutsumi K, Ishikawa K. DNA methylation and the regulation of aldolase B gene expression. J Biochem. 1986 Nov;100(5):1279–1286. [PubMed]
  • Courtois G, Baumhueter S, Crabtree GR. Purified hepatocyte nuclear factor 1 interacts with a family of hepatocyte-specific promoters. Proc Natl Acad Sci U S A. 1988 Nov;85(21):7937–7941. [PubMed]
  • Tsutsumi K, Ito K, Ishikawa K. Developmental appearance of transcription factors that regulate liver-specific expression of the aldolase B gene. Mol Cell Biol. 1989 Nov;9(11):4923–4931. [PMC free article] [PubMed]
  • Tsutsumi K, Ito K, Yabuki T, Ishikawa K. A1F-B, a novel CCAAT-binding transcription activator that interacts with the aldolase B promoter. FEBS Lett. 1993 Apr 19;321(1):51–54. [PubMed]
  • Gregori C, Kahn A, Pichard AL. Activity of the rat liver-specific aldolase B promoter is restrained by HNF3. Nucleic Acids Res. 1994 Apr 11;22(7):1242–1246. [PMC free article] [PubMed]
  • Ito K, Tsutsumi K, Kuzumaki T, Gomez PF, Otsu K, Ishikawa K. A novel growth-inducible gene that encodes a protein with a conserved cold-shock domain. Nucleic Acids Res. 1994 Jun 11;22(11):2036–2041. [PMC free article] [PubMed]
  • Gregori C, Kahn A, Pichard AL. Competition between transcription factors HNF1 and HNF3, and alternative cell-specific activation by DBP and C/EBP contribute to the regulation of the liver-specific aldolase B promoter. Nucleic Acids Res. 1993 Feb 25;21(4):897–903. [PMC free article] [PubMed]
  • Sabourin JC, Kern AS, Grégori C, Porteu A, Cywiner C, Châtelet FP, Kahn A, Pichard AL. An intronic enhancer essential for tissue-specific expression of the aldolase B transgenes. J Biol Chem. 1996 Feb 16;271(7):3469–3473. [PubMed]
  • PEANASKY RJ, LARDY HA. Bovine liver aldolase. I. Isolation, crystallization, and some general properties. J Biol Chem. 1958 Aug;233(2):365–370. [PubMed]
  • Penhoet E, Kochman M, Valentine R, Rutter WJ. The subunit structure of mammalian fructose diphosphate aldolase. Biochemistry. 1967 Sep;6(9):2940–2949. [PubMed]
  • HERS HG, KUSAKA T. Le metabolisme du fructose-1-phosphate dans le foie. Biochim Biophys Acta. 1953 Jul;11(3):427–437. [PubMed]
  • RUTTER WJ. EVOLUTION OF ALDOLASE. Fed Proc. 1964 Nov-Dec;23:1248–1257. [PubMed]
  • Tolan DR, Niclas J, Bruce BD, Lebo RV. Evolutionary implications of the human aldolase-A, -B, -C, and -pseudogene chromosome locations. Am J Hum Genet. 1987 Nov;41(5):907–924. [PubMed]
  • Kawahara K, Tanford C. The number of polypeptide chains in rabbit muscle aldolase. Biochemistry. 1966 May;5(5):1578–1584. [PubMed]
  • Morse DE, Chan W, Horecker BL. The subunit structure and carboxy-terminal sequence of rabbit muscle aldolase. Proc Natl Acad Sci U S A. 1967 Aug;58(2):628–634. [PubMed]
  • Sia CL, Horecker BL. The molecular weight of rabbit muscle aldolase and the properties of the subunits in acid solution. Arch Biochem Biophys. 1968 Jan;123(1):186–194. [PubMed]
  • Sygusch J, Beaudry D, Allaire M. Molecular architecture of rabbit skeletal muscle aldolase at 2.7-A resolution. Proc Natl Acad Sci U S A. 1987 Nov;84(22):7846–7850. [PubMed]
  • Blom N, Sygusch J. Product binding and role of the C-terminal region in class I D-fructose 1,6-bisphosphate aldolase. Nat Struct Biol. 1997 Jan;4(1):36–39. [PubMed]
  • Banner DW, Bloomer AC, Petsko GA, Phillips DC, Pogson CI, Wilson IA, Corran PH, Furth AJ, Milman JD, Offord RE, et al. Structure of chicken muscle triose phosphate isomerase determined crystallographically at 2.5 angstrom resolution using amino acid sequence data. Nature. 1975 Jun 19;255(5510):609–614. [PubMed]
  • Alber T, Banner DW, Bloomer AC, Petsko GA, Phillips D, Rivers PS, Wilson IA. On the three-dimensional structure and catalytic mechanism of triose phosphate isomerase. Philos Trans R Soc Lond B Biol Sci. 1981 Jun 26;293(1063):159–171. [PubMed]
  • Stuart DI, Levine M, Muirhead H, Stammers DK. Crystal structure of cat muscle pyruvate kinase at a resolution of 2.6 A. J Mol Biol. 1979 Oct 15;134(1):109–142. [PubMed]
  • Farber GK, Petsko GA. The evolution of alpha/beta barrel enzymes. Trends Biochem Sci. 1990 Jun;15(6):228–234. [PubMed]
  • Lai CY, Nakai N, Chang D. Amino acid sequence of rabbit muscle aldolase and the structure of the active center. Science. 1974 Mar;183(130):1204–1206. [PubMed]
  • Hartman FC, Brown JP. Affinity labeling of a previously undetected essential lysyl residue in class I fructose bisphosphate aldolase. J Biol Chem. 1976 May 25;251(10):3057–3062. [PubMed]
  • DRECHSLER ER, BOYER PD, KOWALSKY AG. The catalytic activity of carboxypeptidase-degraded aldolase. J Biol Chem. 1959 Oct;234:2627–2634. [PubMed]
  • Takahashi I, Takasaki Y, Hori K. Site-directed mutagenesis of human aldolase isozymes: the role of Cys-72 and Cys-338 residues of aldolase A and of the carboxy-terminal Tyr residues of aldolases A and B. J Biochem. 1989 Feb;105(2):281–286. [PubMed]
  • Henry I, Gallano P, Besmond C, Weil D, Mattei MG, Turleau C, Boué J, Kahn A, Junien C. The structural gene for aldolase B (ALDB) maps to 9q13----32. Ann Hum Genet. 1985 Jul;49(Pt 3):173–180. [PubMed]
  • Lebo RV, Tolan DR, Bruce BD, Cheung MC, Kan YW. Spot-blot analysis of sorted chromosomes assigns a fructose intolerance disease locus to chromosome 9. Cytometry. 1985 Sep;6(5):478–483. [PubMed]
  • Lench NJ, Telford EA, Andersen SE, Moynihan TP, Robinson PA, Markham AF. An EST and STS-based YAC contig map of human chromosome 9q22.3. Genomics. 1996 Dec 1;38(2):199–205. [PubMed]
  • Tolan DR, Penhoet EE. Characterization of the human aldolase B gene. Mol Biol Med. 1986 Jun;3(3):245–264. [PubMed]
  • Kitajima Y, Takasaki Y, Takahashi I, Hori K. Construction and properties of active chimeric enzymes between human aldolases A and B. Analysis of molecular regions which determine isozyme-specific functions. J Biol Chem. 1990 Oct 15;265(29):17493–17498. [PubMed]
  • Shaw-Lee R, Lissemore JL, Sullivan DT, Tolan DR. Alternative splicing of fructose 1,6-bisphosphate aldolase transcripts in Drosophila melanogaster predicts three isozymes. J Biol Chem. 1992 Feb 25;267(6):3959–3967. [PubMed]
  • Kai T, Sugimoto Y, Kusakabe T, Zhang R, Koga K, Hori K. Gene structure and multiple mRNA species of Drosophila melanogaster aldolase generating three isozymes with different enzymatic properties. J Biochem. 1992 Nov;112(5):677–688. [PubMed]
  • Zhang R, Kai T, Sugimoto Y, Kusakabe T, Takasaki Y, Koga K, Hori K. Drosophila melanogaster aldolase: characterization of the isozymes alpha, beta, and gamma generated from a single gene. J Biochem. 1995 Jul;118(1):183–188. [PubMed]
  • HERS HG, JOASSIN G. [Anomaly of hepatic aldolase in intolerance to fructose]. Enzymol Biol Clin (Basel) 1961;1:4–14. [PubMed]
  • CHAMBERS RA, PRATT RT. Idiosyncrasy to fructose. Lancet. 1956 Aug 18;271(6938):340–340. [PubMed]
  • FROESCH ER, PRADER A, LABHART A, STUBER HW, WOLF HP. Die hereditäre Fructoseintoleranz, eine bisher nicht bekannte kongenitale Stoffwechselstörung. Schweiz Med Wochenschr. 1957 Sep 14;87(37):1168–1171. [PubMed]
  • Levin B, Snodgrass GJ, Oberholzer VG, Burgess EA, Dobbs RH. Fructosaemia. Observations on seven cases. Am J Med. 1968 Dec;45(6):826–838. [PubMed]
  • Baerlocher K, Gitzelmann R, Steinmann B, Gitzelmann-Cumarasamy N. Hereditary fructose intolerance in early childhood: a major diagnostic challenge. Survey of 20 symptomatic cases. Helv Paediatr Acta. 1978 Dec;33(6):465–487. [PubMed]
  • Odièvre M, Gentil C, Gautier M, Alagille D. Hereditary fructose intolerance in childhood. Diagnosis, management, and course in 55 patients. Am J Dis Child. 1978 Jun;132(6):605–608. [PubMed]
  • Mock DM, Perman JA, Thaler M, Morris RC., Jr Chronic fructose intoxication after infancy in children with hereditary fructose intolerance. A cause of growth retardation. N Engl J Med. 1983 Sep 29;309(13):764–770. [PubMed]
  • von Ruecker A, Endres W, Shin YS, Butenandt I, Steinmann B, Gitzelmann R. A case of fatal hereditary fructose intolerance. Misleading information of formula composition. Helv Paediatr Acta. 1981;36(6):599–600. [PubMed]
  • Cross NC, Cox TM. Molecular analysis of aldolase B genes in the diagnosis of hereditary fructose intolerance in the United Kingdom. Q J Med. 1989 Nov;73(271):1015–1020. [PubMed]
  • Marthaler TM, Froesch ER. Hereditary fructose intolerance. Dental status of eight patients. Br Dent J. 1967 Dec 19;123(12):597–599. [PubMed]
  • Newbrun E, Hoover C, Mettraux G, Graf H. Comparison of dietary habits and dental health of subjects with hereditary fructose intolerance and control subjects. J Am Dent Assoc. 1980 Oct;101(4):619–626. [PubMed]
  • Saxén L, Jousimies-Somer H, Kaisla A, Kanervo A, Summanen P, Sipilä I. Subgingival microflora, dental and periodontal conditions in patients with hereditary fructose intolerance. Scand J Dent Res. 1989 Apr;97(2):150–158. [PubMed]
  • Cox TM. Iatrogenic deaths in hereditary fructose intolerance. Arch Dis Child. 1993 Oct;69(4):413–415. [PMC free article] [PubMed]
  • Cox TM. Therapeutic use of fructose: professional freedom, 'pharmacovigilance' and Europe. QJM. 1995 Apr;88(4):225–227. [PubMed]
  • Schulte MJ, Lenz W. Fatal sorbitol infusion in patient with fructose-sorbitol intolerance. Lancet. 1977 Jul 23;2(8030):188–188. [PubMed]
  • Müller-Wiefel DE, Steinmann B, Holm-Hadulla M, Wille L, Schärer K, Gitzelmann R. Infusionsbedingtes Nieren- und Leberversagen bei undiagnostizierter hereditärer Fructose-Intoleranz. Dtsch Med Wochenschr. 1983 Jun 24;108(25):985–989. [PubMed]
  • Steegmanns I, Rittmann M, Bayerl JR, Gitzelmann R. Erwachsene mit hereditärer Fructoseintoleranz: Gefährdung durch Fructoseinfusion. Dtsch Med Wochenschr. 1990 Apr 6;115(14):539–541. [PubMed]
  • Rosien U, Cox TM, Ali M, Dignass A, Daul A, Layer P, Hager W. Akutes hepatorenales Versagen bei hereditärer Fructoseintoleranz. Med Klin (Munich) 1993 Sep 15;88(9):553–554. [PubMed]
  • MILLER M, DRUCKER WR, OWENS JE, CRAIG JW, WOODWARD H., Jr Metabolism of intravenous fructose and glucose in normal and diabetic subjects. J Clin Invest. 1952 Jan;31(1):115–125. [PMC free article] [PubMed]
  • Danks DM, Connellan JM, Solomon JR. Hereditary fructose intolerance: report of a case and comments on the hazards of fructose infusion. Aust Paediatr J. 1972 Oct;8(5):282–286. [PubMed]
  • Woods HF, Alberti KG. Dangers of intravenous fructose. Lancet. 1972 Dec 23;2(7791):1354–1357. [PubMed]
  • Perheentupa J, Raivio K. Fructose-induced hyperuricaemia. Lancet. 1967 Sep 9;2(7515):528–531. [PubMed]
  • Bergström J, Hultman E, Roch-Norlund AE. Lactic acid accumulation in connection with fructose infusion. Acta Med Scand. 1968 Nov;184(5):359–364. [PubMed]
  • Odièvre M, Gautier M, Rieu D. Intolérance héréditaire au fructose du nourrisson: évolution des lésions histologiques hépatiques sous traitement diététique prolongé (étude de huit observations) Arch Fr Pediatr. 1969 Apr;26(4):433–443. [PubMed]
  • CORI GT, OCHOA S, SLEIN MW, CORI CF. The metabolism of fructose in liver; isolation of fructose-I-phosphate and inorganic pyrophosphate. Biochim Biophys Acta. 1951 Jul;7(2):304–317. [PubMed]
  • HERS HG. La fructokinase du foie. Biochim Biophys Acta. 1952 Apr;8(4):416–423. [PubMed]
  • FROESCH ER, WOLF HP, BAITSCH H, PRADER A, LABHART A. Hereditary fructose intolerance. An inborn defect of hepatic fructose-1-phosphate splitting aldolase. Am J Med. 1963 Feb;34:151–167. [PubMed]
  • PITKANEN E, PERHEENTUPA J. [A biochemical investigation on 2 cases of fructose intolerance]. Ann Paediatr Fenn. 1962;8:236–244. [PubMed]
  • Landau BR, Marshall JS, Craig JW, Hostetler KY, Genuth SM. Quantitation of the pathways of fructose metabolism in normal and fructose-intolerant subjects. J Lab Clin Med. 1971 Oct;78(4):608–618. [PubMed]
  • FROESCH ER, GINSBERG JL. Fructose metabolism of adipose tissue. I. Comparison of fructose and glucose metabolism in epididymal adipose tissue of normal rats. J Biol Chem. 1962 Nov;237:3317–3324. [PubMed]
  • Woods HF, Eggleston LV, Krebs HA. The cause of hepatic accumulation of fructose 1-phosphate on fructose loading. Biochem J. 1970 Sep;119(3):501–510. [PubMed]
  • Watts RW, Watts JE, Seegmiller JE. Xanthine oxidase activity in human tissues and its inhibition by allopurinol (4-hydroxypyrazolo[3,4-d] pyrimidine). J Lab Clin Med. 1965 Oct;66(4):688–697. [PubMed]
  • Bode JC, Zelder O, Rumpelt HJ, Wittkamp U. Depletion of liver adenosine phosphates and metabolic effects of intravenous infusion of fructose or sorbitol in man and in the rat. Eur J Clin Invest. 1973 Sep;3(5):436–441. [PubMed]
  • van den Berghe G, Bronfman M, Vanneste R, Hers HG. The mechanism of adenosine triphosphate depletion in the liver after a load of fructose. A kinetic study of liver adenylate deaminase. Biochem J. 1977 Mar 15;162(3):601–609. [PubMed]
  • Oberhaensli RD, Rajagopalan B, Taylor DJ, Radda GK, Collins JE, Leonard JV, Schwarz H, Herschkowitz N. Study of hereditary fructose intolerance by use of 31P magnetic resonance spectroscopy. Lancet. 1987 Oct 24;2(8565):931–934. [PubMed]
  • Mäenpä PH. Fructose-induced alterations in liver polysome profiles and Mg 2+ levels. FEBS Lett. 1972 Jul 15;24(1):37–40. [PubMed]
  • LEVIN B, OBERHOLZER VG, SNODGRASS GJ, STIMMLER L, WILMERS MJ. Fructosaemia: an inborn error of fructose metabolism. Arch Dis Child. 1963 Jun;38:220–230. [PMC free article] [PubMed]
  • PARKS RE, Jr, BEN-GERSHOM E, LARDY HA. Liver fructokinase. J Biol Chem. 1957 Jul;227(1):231–242. [PubMed]
  • SMITH LH, Jr, ETTINGER RH, SELIGSON D. A comparison of the metabolism of fructose and glucose in hepatic disease and diabetes mellitus. J Clin Invest. 1953 Apr;32(4):273–282. [PMC free article] [PubMed]
  • Kaufmann U, Froesch ER. Inhibition of phosphorylase-a by fructose-1-phosphate, alpha-glycerophosphate and fructose-1,6-diphosphate: explanation for fructose-induced hypoglycaemia in hereditary fructose intolerance and fructose-1,6-diphosphatase deficiency. Eur J Clin Invest. 1973 Sep;3(5):407–413. [PubMed]
  • Van Den Berghe G, Hue L, Hers HG. Effect of administration of the fructose on the glycogenolytic action of glucagon. An investigation of the pathogeny of hereditary fructose intolerance. Biochem J. 1973 Jun;134(2):637–645. [PubMed]
  • Thurston JH, Jones EM, Hauhart RE. Decrease and inhibition of liver glycogen phosphorylase after fructose. An experimental model for the study of hereditary fructose intolerance. Diabetes. 1974 Jul;23(7):597–604. [PubMed]
  • FROESCH ER, PRADER A, WOLF HP, LABHART A. Die hereditäre Fructoseintoleranz. Helv Paediatr Acta. 1959 Jun;14(2):99–112. [PubMed]
  • Zalitis J, Oliver IT. Inhibition of glucose phosphate isomerase by metabolic intermediates of fructose. Biochem J. 1967 Mar;102(3):753–759. [PubMed]
  • Eggleston LV, Woods HF. Activation of liver pyruvate kinase by fructose-1-phosphate. FEBS Lett. 1970 Jan 15;6(1):43–45. [PubMed]
  • Andersson G, Brohult J, Sterner G. Increasing metabolic acidosis following fructose infusion in two children. Acta Paediatr Scand. 1969 May;58(3):301–304. [PubMed]
  • Morris RC., Jr An experimental renal acidification defect in patients with hereditary fructose intolerance. II. Its distinction from classic renal tubular acidosis; its resemblance to the renal acidification defect associated with the Fanconi syndrome of children with cystinosis. J Clin Invest. 1968 Jul;47(7):1648–1663. [PMC free article] [PubMed]
  • Richardson RM, Little JA, Patten RL, Goldstein MB, Halperin ML. Pathogenesis of acidosis in hereditary fructose intolerance. Metabolism. 1979 Nov;28(11):1133–1138. [PubMed]
  • PAPPER S, SAXON L. Abdominal pain occurring during the rapid administration of fructose solutions. N Engl J Med. 1957 Jan 17;256(3):132–133. [PubMed]
  • Cross NC, Tolan DR, Cox TM. Catalytic deficiency of human aldolase B in hereditary fructose intolerance caused by a common missense mutation. Cell. 1988 Jun 17;53(6):881–885. [PubMed]
  • Cox TM, O'Donnell MW, Camilleri M, Burghes AH. Isolation and characterization of a mutant liver aldolase in adult hereditary fructose intolerance. Identification of the enzyme variant by radioassay in tissue biopsy specimens. J Clin Invest. 1983 Jul;72(1):201–213. [PMC free article] [PubMed]
  • James CL, Rellos P, Ali M, Heeley AF, Cox TM. Neonatal screening for hereditary fructose intolerance: frequency of the most common mutant aldolase B allele (A149P) in the British population. J Med Genet. 1996 Oct;33(10):837–841. [PMC free article] [PubMed]
  • Cross NC, de Franchis R, Sebastio G, Dazzo C, Tolan DR, Gregori C, Odievre M, Vidailhet M, Romano V, Mascali G, et al. Molecular analysis of aldolase B genes in hereditary fructose intolerance. Lancet. 1990 Feb 10;335(8685):306–309. [PubMed]
  • Cox TM. Aldolase B and fructose intolerance. FASEB J. 1994 Jan;8(1):62–71. [PubMed]
  • Tolan DR, Brooks CC. Molecular analysis of common aldolase B alleles for hereditary fructose intolerance in North Americans. Biochem Med Metab Biol. 1992 Aug;48(1):19–25. [PubMed]
  • Ali M, James CL, Cox TM. A newly identified aldolase B splicing mutation (G-->C, 5' intron 5) in hereditary fructose intolerance from New Zealand. Hum Mutat. 1996;7(2):155–157. [PubMed]
  • Sebastio G, de Franchis R, Strisciuglio P, Andria G, Dionisi Vici C, Sabetta G, Gatti R, Cross NC, Cox TM. Aldolase B mutations in Italian families affected by hereditary fructose intolerance. J Med Genet. 1991 Apr;28(4):241–243. [PMC free article] [PubMed]
  • Brooks CC, Tolan DR. Association of the widespread A149P hereditary fructose intolerance mutation with newly identified sequence polymorphisms in the aldolase B gene. Am J Hum Genet. 1993 Apr;52(4):835–840. [PubMed]
  • Cross NC, Stojanov LM, Cox TM. A new aldolase B variant, N334K, is a common cause of hereditary fructose intolerance in Yugoslavia. Nucleic Acids Res. 1990 Apr 11;18(7):1925–1925. [PMC free article] [PubMed]
  • Dazzo C, Tolan DR. Molecular evidence for compound heterozygosity in hereditary fructose intolerance. Am J Hum Genet. 1990 Jun;46(6):1194–1199. [PubMed]
  • Cox TM, O'Donnell MW, Camilleri M. Allelic heterogeneity in adult hereditary fructose intolerance. Detection of structural mutations in the aldolase B molecule. Mol Biol Med. 1983 Nov;1(4):393–400. [PubMed]
  • Santamaria R, Scarano MI, Esposito G, Chiandetti L, Izzo P, Salvatore F. The molecular basis of hereditary fructose intolerance in Italian children. Eur J Clin Chem Clin Biochem. 1993 Oct;31(10):675–678. [PubMed]
  • Santamaria R, Tamasi S, Del Piano G, Sebastio G, Andria G, Borrone C, Faldella G, Izzo P, Salvatore F. Molecular basis of hereditary fructose intolerance in Italy: identification of two novel mutations in the aldolase B gene. J Med Genet. 1996 Sep;33(9):786–788. [PMC free article] [PubMed]
  • Ali M, Cox TM. Diverse mutations in the aldolase B gene that underlie the prevalence of hereditary fructose intolerance. Am J Hum Genet. 1995 Apr;56(4):1002–1005. [PubMed]
  • Ali M, Tunçman G, Cross NC, Vidailhet M, Bökesoy I, Gitzelmann R, Cox TM. Null alleles of the aldolase B gene in patients with hereditary fructose intolerance. J Med Genet. 1994 Jun;31(6):499–503. [PMC free article] [PubMed]
  • Brooks CC, Tolan DR. A partially active mutant aldolase B from a patient with hereditary fructose intolerance. FASEB J. 1994 Jan;8(1):107–113. [PubMed]
  • Ali M, Rosien U, Cox TM. DNA diagnosis of fatal fructose intolerance from archival tissue. Q J Med. 1993 Jan;86(1):25–30. [PubMed]
  • Cross NC, Cox TM. Partial aldolase B gene deletions in hereditary fructose intolerance. Am J Hum Genet. 1990 Jul;47(1):101–106. [PubMed]
  • Kajihara S, Mukai T, Arai Y, Owada M, Kitagawa T, Hori K. Hereditary fructose intolerance caused by a nonsense mutation of the aldolase B gene. Am J Hum Genet. 1990 Sep;47(3):562–567. [PubMed]
  • Nordmann Y, Schapira F, Dreyfus JC. A structurally modified liver aldolase in fructose intolerance: immunological and kinetic evidence. Biochem Biophys Res Commun. 1968 Jun 28;31(6):884–889. [PubMed]
  • Gitzelmann R, Steinmann B, Bally C, Lebherz HG. Antibody activation of mutant human fructosediphosphate aldolase B in liver extracts of patients with hereditary fructose intolerance. Biochem Biophys Res Commun. 1974 Aug 19;59(4):1270–1277. [PubMed]
  • Lameire N, Mussche M, Baele G, Kint J, Ringoir S. Hereditary fructose intolerance: a difficult diagnosis in the adult. Am J Med. 1978 Sep;65(3):416–423. [PubMed]
  • Schapira F, Hatzfeld A, Gregori C. Studies on liver aldolases in hereditary fructose intolerance. Enzyme. 1974;18(1):73–83. [PubMed]
  • Grégori C, Schapira F, Kahn A, Delpech M, Dreyfus JC. Molecular studies of liver aldolase B in hereditary fructose intolerance using blotting and immunological techniques. Ann Hum Genet. 1982 Oct;46(Pt 4):281–292. [PubMed]
  • Sakakibara M, Takahashi I, Takasaki Y, Mukai T, Hori K. Construction and expression of human aldolase A and B expression plasmids in Escherichia coli host. Biochim Biophys Acta. 1989 Apr 12;1007(3):334–342. [PubMed]
  • Gamblin SJ, Davies GJ, Grimes JM, Jackson RM, Littlechild JA, Watson HC. Activity and specificity of human aldolases. J Mol Biol. 1991 Jun 20;219(4):573–576. [PubMed]
  • Morris AJ, Tolan DR. Lysine-146 of rabbit muscle aldolase is essential for cleavage and condensation of the C3-C4 bond of fructose 1,6-bis(phosphate). Biochemistry. 1994 Oct 11;33(40):12291–12297. [PubMed]
  • Berthiaume L, Tolan DR, Sygusch J. Differential usage of the carboxyl-terminal region among aldolase isozymes. J Biol Chem. 1993 May 25;268(15):10826–10835. [PubMed]
  • Motoki K, Kitajima Y, Hori K. Isozyme-specific modules on human aldolase A molecule. Isozyme group-specific sequences 1 and 4 are required for showing characteristics as aldolase A. J Biol Chem. 1993 Jan 25;268(3):1677–1683. [PubMed]
  • Ali M, Sebastio G, Cox TM. Identification of a novel mutation (Leu 256-->Pro) in the human aldolase B gene associated with hereditary fructose intolerance. Hum Mol Genet. 1994 Jan;3(1):203–204. [PubMed]
  • Beernink PT, Tolan DR. Subunit interface mutants of rabbit muscle aldolase form active dimers. Protein Sci. 1994 Sep;3(9):1383–1391. [PubMed]
  • Beernink PT, Tolan DR. Disruption of the aldolase A tetramer into catalytically active monomers. Proc Natl Acad Sci U S A. 1996 May 28;93(11):5374–5379. [PubMed]
  • Cox TM, Camilleri M, O'Donnell MW, Chadwick VS. Pseudodominant transmission of fructose intolerance in an adult and three offspring: Heterozygote detection by intestinal biopsy. N Engl J Med. 1982 Aug 26;307(9):537–540. [PubMed]
  • Steinmann B, Gitzelmann R. The diagnosis of hereditary fructose intolerance. Helv Paediatr Acta. 1981 Sep;36(4):297–316. [PubMed]
  • Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 1985 Dec 20;230(4732):1350–1354. [PubMed]
  • WOLF H, ZSCHOCKE D, WEDEMEYER FW, HUBNER W. Angeborene hereditäre Fructose-Intoleranz. Klin Wochenschr. 1959 Jul 1;37(13):693–696. [PubMed]
  • LINDEN L, NISELL J. HEREDITAER FRUKTOSINTOLERANS. Sven Lakartidn. 1964 Oct 21;61:3185–3195. [PubMed]
  • Barry RG, St Colum, Magner JW. Hereditary fructose intolerance in parent and child. J Ir Med Assoc. 1968 Sep;61(375):308–310. [PubMed]
  • Heine W, Schill H, Tessmann D, Kupatz H. Letale Leberdystrophie bei drei Geschwistern mit hereditärer Fruktoseintoleranz nach Dauertropfinfusionen mit Sorbitolhaltigen Infusionslösungen. Dtsch Gesundheitsw. 1969 Dec 4;24(49):2325–2329. [PubMed]
  • Hackl JM, Balogh D, Kunz F, Dworzak E, Puschendorf B, Decristoforo A, Maier F. Postoperative Fruktoseinfusion bei wahrscheinlich hereditärer Fruktoseintoleranz. Wien Klin Wochenschr. 1978 Mar 31;90(7):237–240. [PubMed]
  • Rey M, Behrens R, Zeilinger G. Fatale Folgen einer Fructose-Infusion bei undiagnostizierter Fructose-Intoleranz. Dtsch Med Wochenschr. 1988 Jun 10;113(23):945–947. [PubMed]
  • Brooks CC, Buist N, Tuerck J, Tolan DR. Identification of a splice-site mutation in the aldolase B gene from an individual with hereditary fructose intolerance. Am J Hum Genet. 1991 Nov;49(5):1075–1081. [PubMed]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group